Additive Proarrhythmic Effect of Combined Treatment with QT-Prolonging Agents.

MLA

Frommeyer, Gerrit, et al. “Additive Proarrhythmic Effect of Combined Treatment with QT-Prolonging Agents.” Cardiovascular Toxicology, vol. 18, no. 1, Feb. 2018, pp. 84–90. EBSCOhost, https://doi.org/10.1007/s12012-017-9416-0.

APA

Frommeyer, G., Fischer, C., Ellermann, C., Dechering, D. G., Kochhäuser, S., Lange, P. S., Wasmer, K., Fehr, M., & Eckardt, L. (2018). Additive Proarrhythmic Effect of Combined Treatment with QT-Prolonging Agents. Cardiovascular Toxicology, 18(1), 84–90. https://doi.org/10.1007/s12012-017-9416-0

Chicago

Frommeyer, Gerrit, Christina Fischer, Christian Ellermann, Dirk G. Dechering, Simon Kochhäuser, Philipp S. Lange, Kristina Wasmer, Michael Fehr, and Lars Eckardt. 2018. “Additive Proarrhythmic Effect of Combined Treatment with QT-Prolonging Agents.” Cardiovascular Toxicology 18 (1): 84–90. doi:10.1007/s12012-017-9416-0.